Published in Cancer Res on February 16, 2010
PD-L1 expression is increased in a subset of basal type breast cancer cells. PLoS One (2014) 1.46
Live free or die: tales of homeless (cells) in cancer. Am J Pathol (2010) 1.15
Distinct roles of AKT isoforms in regulating β1-integrin activity, migration, and invasion in prostate cancer. Mol Biol Cell (2012) 1.09
Trop-2 promotes prostate cancer metastasis by modulating β(1) integrin functions. Cancer Res (2013) 1.04
Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer. Cancer Sci (2015) 1.04
The primacy of β1 integrin activation in the metastatic cascade. PLoS One (2012) 1.03
Targeting constitutively activated β1 integrins inhibits prostate cancer metastasis. Mol Cancer Res (2013) 1.01
Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK). Proc Natl Acad Sci U S A (2011) 1.00
Talin1 phosphorylation activates β1 integrins: a novel mechanism to promote prostate cancer bone metastasis. Oncogene (2014) 1.00
MiR-124 suppresses cell motility and adhesion by targeting talin 1 in prostate cancer cells. Cancer Cell Int (2015) 0.99
FOXA1 promotes tumor progression in prostate cancer via the insulin-like growth factor binding protein 3 pathway. PLoS One (2012) 0.99
Modulation of MicroRNA-194 and cell migration by HER2-targeting trastuzumab in breast cancer. PLoS One (2012) 0.99
A targeted RNAi screen of the breast cancer genome identifies KIF14 and TLN1 as genes that modulate docetaxel chemosensitivity in triple-negative breast cancer. Clin Cancer Res (2013) 0.98
Translation initiation factor eIF3b expression in human cancer and its role in tumor growth and lung colonization. Clin Cancer Res (2013) 0.94
IGF-IR promotes prostate cancer growth by stabilizing α5β1 integrin protein levels. PLoS One (2013) 0.93
Cryptotanshinone suppresses androgen receptor-mediated growth in androgen dependent and castration resistant prostate cancer cells. Cancer Lett (2011) 0.93
EMMPRIN regulates cytoskeleton reorganization and cell adhesion in prostate cancer. Prostate (2011) 0.92
Nanog and Oct4 overexpression increases motility and transmigration of melanoma cells. J Cancer Res Clin Oncol (2012) 0.91
Network-based prediction for sources of transcriptional dysregulation using latent pathway identification analysis. Proc Natl Acad Sci U S A (2011) 0.90
Cytoskeleton targeting value in prostate cancer treatment. Am J Clin Exp Urol (2014) 0.90
Integrin αβ1, αvβ, α6β effectors p130Cas, Src and talin regulate carcinoma invasion and chemoresistance. Biochem Biophys Res Commun (2011) 0.87
Resistance to the mTOR-inhibitor RAD001 elevates integrin α2- and β1-triggered motility, migration and invasion of prostate cancer cells. Br J Cancer (2012) 0.87
Receptor-interacting protein (RIP) and Sirtuin-3 (SIRT3) are on opposite sides of anoikis and tumorigenesis. Cancer (2012) 0.86
Cathepsin H mediates the processing of talin and regulates migration of prostate cancer cells. J Biol Chem (2012) 0.86
Nuclear localization of parathyroid hormone-related peptide confers resistance to anoikis in prostate cancer cells. Endocr Relat Cancer (2012) 0.86
Actinin-4 in keratinocytes regulates motility via an effect on lamellipodia stability and matrix adhesions. FASEB J (2012) 0.86
Constitutively active c-Met kinase in PC-3 cells is autocrine-independent and can be blocked by the Met kinase inhibitor BMS-777607. BMC Cancer (2012) 0.86
Cholestane-3β, 5α, 6β-triol suppresses proliferation, migration, and invasion of human prostate cancer cells. PLoS One (2013) 0.85
Contributions of talin-1 to glioma cell-matrix tensional homeostasis. J R Soc Interface (2011) 0.84
Phosphatidylinositol phosphate 5-kinase Iγi2 in association with Src controls anchorage-independent growth of tumor cells. J Biol Chem (2013) 0.84
A four actin-binding protein signature model for poor prognosis of patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol (2014) 0.84
Autoantibody signatures as biomarkers to distinguish prostate cancer from benign prostatic hyperplasia in patients with increased serum prostate specific antigen. Clin Chim Acta (2011) 0.83
Occupy tissue: the movement in cancer metastasis. Cell Adh Migr (2012) 0.83
Inflammation in prostate cancer progression and therapeutic targeting. Transl Androl Urol (2015) 0.83
Structural and mechanistic insights into the recruitment of talin by RIAM in integrin signaling. Structure (2014) 0.83
Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review). Oncol Rep (2016) 0.83
Resveratrol suppresses human colon cancer cell proliferation and induces apoptosis via targeting the pentose phosphate and the talin-FAK signaling pathways-A proteomic approach. Proteome Sci (2011) 0.82
High FAK combined with low JWA expression: clinical prognostic and predictive role for adjuvant fluorouracil-leucovorin-oxaliplatin treatment in resectable gastric cancer patients. J Gastroenterol (2013) 0.82
Pleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasis. Proc Natl Acad Sci U S A (2012) 0.82
FH535 inhibited metastasis and growth of pancreatic cancer cells. Onco Targets Ther (2015) 0.81
Carcinoma matrix controls resistance to cisplatin through talin regulation of NF-kB. PLoS One (2011) 0.81
Anoikis mediators in oral squamous cell carcinoma. Oral Dis (2010) 0.81
Anoikis and EMT: Lethal "Liaisons" during Cancer Progression. Crit Rev Oncog (2016) 0.81
Novel pharmacologic targeting of tight junctions and focal adhesions in prostate cancer cells. PLoS One (2014) 0.81
Upregulation of Talin-1 expression associates with advanced pathological features and predicts lymph node metastases and biochemical recurrence of prostate cancer. Medicine (Baltimore) (2016) 0.80
The role of phosphoinositide-regulated actin reorganization in chemotaxis and cell migration. Br J Pharmacol (2014) 0.80
The ZNF304-integrin axis protects against anoikis in cancer. Nat Commun (2015) 0.79
High expression of Talin-1 is associated with poor prognosis in patients with nasopharyngeal carcinoma. BMC Cancer (2015) 0.79
Common Effects on Cancer Cells Exerted by a Random Positioning Machine and a 2D Clinostat. PLoS One (2015) 0.79
Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate Cancer. Cancer Res (2015) 0.79
Underexpression of LKB1 tumor suppressor is associated with enhanced Wnt signaling and malignant characteristics of human intrahepatic cholangiocarcinoma. Oncotarget (2015) 0.78
Both Talin-1 and Talin-2 correlate with malignancy potential of the human hepatocellular carcinoma MHCC-97 L cell. BMC Cancer (2016) 0.78
Integrin-linked kinase 1: role in hormonal cancer progression. Front Biosci (Schol Ed) (2011) 0.78
Talin1 targeting potentiates anti-angiogenic therapy by attenuating invasion and stem-like features of glioblastoma multiforme. Oncotarget (2015) 0.78
Dissecting dysfunctional crosstalk pathways regulated by miRNAs during glioma progression. Oncotarget (2016) 0.77
Cooperative Stimulation of Megakaryocytic Differentiation by Gfi1b Gene Targets Kindlin3 and Talin1. PLoS One (2016) 0.76
Talin Modulation by a Synthetic N-Acylurea Derivative Reduces Angiogenesis in Human Endothelial Cells. Int J Mol Sci (2017) 0.75
Overexpression of NOTCH-regulated Ankyrin Repeat Protein is associated with papillary thyroid carcinoma progression. PLoS One (2017) 0.75
Down-regulation of Talin1 promotes hepatocellular carcinoma progression via activation of the ERK1/2 pathway. Cancer Sci (2017) 0.75
In silico functional profiling of individual prostate cancer tumors: many genes, few functions. Cancer Genomics Proteomics (2012) 0.75
TRPV4 plays a role in breast cancer cell migration via Ca(2+)-dependent activation of AKT and downregulation of E-cadherin cell cortex protein. Oncogenesis (2017) 0.75
Integrin signaling. Science (1999) 16.44
Prostate cancer in a transgenic mouse. Proc Natl Acad Sci U S A (1995) 8.16
Automated subcellular localization and quantification of protein expression in tissue microarrays. Nat Med (2002) 8.04
Anoikis mechanisms. Curr Opin Cell Biol (2001) 6.36
Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature (1996) 6.02
Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol (2005) 5.00
Integrin-linked kinase: a cancer therapeutic target unique among its ILK. Nat Rev Cancer (2005) 3.83
Integrin activation. J Cell Sci (2004) 3.02
The phosphotyrosine binding-like domain of talin activates integrins. J Biol Chem (2002) 2.97
Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J Cell Biol (2001) 2.54
Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression. J Biol Chem (1997) 2.47
Talin is essential for integrin function in Drosophila. Dev Cell (2002) 2.38
Pathologic progression of autochthonous prostate cancer in the TRAMP model. Prostate Cancer Prostatic Dis (1999) 2.37
Quantitative cancer proteomics: stable isotope labeling with amino acids in cell culture (SILAC) as a tool for prostate cancer research. Mol Cell Proteomics (2004) 2.00
Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate. Hum Pathol (2004) 1.82
PINCH-1 is an obligate partner of integrin-linked kinase (ILK) functioning in cell shape modulation, motility, and survival. J Biol Chem (2003) 1.82
Integrin-independent repression of cadherin transcription by talin during axis formation in Drosophila. Nat Cell Biol (2005) 1.76
The integrin-growth factor receptor duet. J Cell Physiol (2007) 1.75
An interaction between integrin and the talin FERM domain mediates integrin activation but not linkage to the cytoskeleton. Nat Cell Biol (2006) 1.67
Integrin-linked kinase regulates phosphorylation of serine 473 of protein kinase B by an indirect mechanism. Oncogene (1999) 1.67
The integrin-linked kinase (ILK) suppresses anoikis. Oncogene (2000) 1.59
Integrins and prostate cancer metastases. Cancer Metastasis Rev (2001) 1.51
Anoikis and survival connections in the tumor microenvironment: is there a role in prostate cancer metastasis? Cancer Res (2005) 1.39
Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways. J Cell Physiol (2007) 1.39
3-(Hydroxymethyl)-bearing phosphatidylinositol ether lipid analogues and carbonate surrogates block PI3-K, Akt, and cancer cell growth. J Med Chem (2000) 1.38
Apoptosis evasion: the role of survival pathways in prostate cancer progression and therapeutic resistance. J Cell Biochem (2006) 1.22
Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma. World J Gastroenterol (2005) 1.19
Talin phosphorylation sites mapped by mass spectrometry. J Cell Sci (2005) 1.19
A cytoskeleton-based functional genetic screen identifies Bcl-xL as an enhancer of metastasis, but not primary tumor growth. Oncogene (2004) 1.11
Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion. J Cell Biochem (2005) 1.02
Recruitment of focal adhesion kinase and paxillin to beta1 integrin promotes cancer cell migration via mitogen activated protein kinase activation. BMC Cancer (2004) 0.99
Identification and characterization of a mouse protein kinase that is highly homologous to human integrin-linked kinase. Biochim Biophys Acta (1997) 0.98
Transcriptional regulation of endothelial nitric-oxide synthase by lysophosphatidylcholine. J Biol Chem (1998) 0.89
Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth. J Biomed Sci (2005) 0.82
Paracrine regulation of talin mRNA expression by androgen in human prostate. FEBS Lett (1998) 0.79
Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol (2004) 6.99
Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer (2007) 3.57
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets. Cancer Discov (2011) 3.43
Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. Am J Pathol (2006) 3.30
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. N Engl J Med (2015) 3.00
Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS One (2008) 2.67
Gene expression analysis of prostate cancers. Mol Carcinog (2002) 2.51
High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey. Cancer Epidemiol Biomarkers Prev (2002) 2.46
Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2009) 2.43
Tubulin-targeting chemotherapy impairs androgen receptor activity in prostate cancer. Cancer Res (2010) 2.42
The development of common data elements for a multi-institute prostate cancer tissue bank: the Cooperative Prostate Cancer Tissue Resource (CPCTR) experience. BMC Cancer (2005) 2.35
Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. Carcinogenesis (2003) 2.33
Immunodetection of DNA repair endonuclease ERCC1-XPF in human tissue. Cancer Res (2009) 2.03
An informatics model for tissue banks--lessons learned from the Cooperative Prostate Cancer Tissue Resource. BMC Cancer (2006) 1.97
The development and deployment of Common Data Elements for tissue banks for translational research in cancer - an emerging standard based approach for the Mesothelioma Virtual Tissue Bank. BMC Cancer (2008) 1.88
Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors. BMC Cancer (2005) 1.87
The cooperative prostate cancer tissue resource: a specimen and data resource for cancer researchers. Clin Cancer Res (2004) 1.85
Development and independent validation of a prognostic assay for stage II colon cancer using formalin-fixed paraffin-embedded tissue. J Clin Oncol (2011) 1.84
Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate. Hum Pathol (2004) 1.82
Effect of alpha1-adrenoceptor antagonist exposure on prostate cancer incidence: an observational cohort study. J Urol (2007) 1.77
A novel cross-disciplinary multi-institute approach to translational cancer research: lessons learned from Pennsylvania Cancer Alliance Bioinformatics Consortium (PCABC). Cancer Inform (2007) 1.76
The tissue microarray data exchange specification: implementation by the Cooperative Prostate Cancer Tissue Resource. BMC Bioinformatics (2004) 1.74
Androgen receptor and growth factor signaling cross-talk in prostate cancer cells. Endocr Relat Cancer (2008) 1.70
Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells. FASEB J (2009) 1.67
Optimization of the Affymetrix GeneChip Mapping 10K 2.0 Assay for routine clinical use on formalin-fixed paraffin-embedded tissues. Diagn Mol Pathol (2008) 1.64
Using the epigenetic field defect to detect prostate cancer in biopsy negative patients. J Urol (2012) 1.60
Retracted Psoralidin, an herbal molecule, inhibits phosphatidylinositol 3-kinase-mediated Akt signaling in androgen-independent prostate cancer cells. Cancer Prev Res (Phila) (2009) 1.57
Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays. Proc Natl Acad Sci U S A (2002) 1.53
Anoikis disruption of focal adhesion-Akt signaling impairs renal cell carcinoma. Eur Urol (2011) 1.51
The development and testing of a laboratory information system-driven tool for pre-sign-out quality assurance of random surgical pathology reports. Am J Clin Pathol (2010) 1.50
Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer. Neoplasia (2013) 1.49
Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma. Hum Pathol (2006) 1.41
Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck. Cancer Res (2007) 1.40
Anoikis and survival connections in the tumor microenvironment: is there a role in prostate cancer metastasis? Cancer Res (2005) 1.39
Diallyl trisulfide suppresses growth of PC-3 human prostate cancer xenograft in vivo in association with Bax and Bak induction. Clin Cancer Res (2006) 1.38
Intrasteric inhibition mediates the interaction of the I/LWEQ module proteins Talin1, Talin2, Hip1, and Hip12 with actin. Biochemistry (2004) 1.38
Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases. Cancer Microenviron (2011) 1.37
Garlic constituent diallyl trisulfide prevents development of poorly differentiated prostate cancer and pulmonary metastasis multiplicity in TRAMP mice. Cancer Res (2008) 1.35
Phenethyl isothiocyanate-induced apoptosis in PC-3 human prostate cancer cells is mediated by reactive oxygen species-dependent disruption of the mitochondrial membrane potential. Carcinogenesis (2006) 1.33
Talin2 is induced during striated muscle differentiation and is targeted to stable adhesion complexes in mature muscle. Cell Motil Cytoskeleton (2007) 1.28
Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor-independent action. Cancer Res (2002) 1.26
Targeting TGF-beta in prostate cancer: therapeutic possibilities during tumor progression. Expert Opin Ther Targets (2009) 1.25
Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion. Cancer Res (2010) 1.23
Apoptosis evasion: the role of survival pathways in prostate cancer progression and therapeutic resistance. J Cell Biochem (2006) 1.22
Prostate cancer risk is three-fold higher among men, aged 50-64, of African descent compared with men of Asian-Indian descent in Trinidad and Tobago. Ethn Dis (2002) 1.22
A positive feedback loop between protein kinase CKII and Cdc37 promotes the activity of multiple protein kinases. J Biol Chem (2002) 1.22
Doxazosin induces apoptosis of benign and malignant prostate cells via a death receptor-mediated pathway. Cancer Res (2006) 1.21
Selective activation of members of the signal transducers and activators of transcription family in prostate carcinoma. J Urol (2002) 1.20
Targeting anoikis resistance in prostate cancer metastasis. Mol Aspects Med (2010) 1.19
Diosgenin targets Akt-mediated prosurvival signaling in human breast cancer cells. Int J Cancer (2009) 1.18
Nicotine activates cell-signaling pathways through muscle-type and neuronal nicotinic acetylcholine receptors in non-small cell lung cancer cells. Pulm Pharmacol Ther (2006) 1.17
Combined analysis of estrogen receptor beta-1 and progesterone receptor expression identifies lung cancer patients with poor outcome. Clin Cancer Res (2010) 1.17
Expression analysis of Ubc9, the single small ubiquitin-like modifier (SUMO) E2 conjugating enzyme, in normal and malignant tissues. Hum Pathol (2010) 1.16
Prostate tumor growth and recurrence can be modulated by the omega-6:omega-3 ratio in diet: athymic mouse xenograft model simulating radical prostatectomy. Neoplasia (2006) 1.16
Prohibitin and cofilin are intracellular effectors of transforming growth factor beta signaling in human prostate cancer cells. Cancer Res (2006) 1.15
Live free or die: tales of homeless (cells) in cancer. Am J Pathol (2010) 1.15
Endocytosis plays a critical role in proteolytic processing of the Hendra virus fusion protein. J Virol (2005) 1.15
Prevalence of incidental prostate cancer in the general population: a study of healthy organ donors. J Urol (2008) 1.14
A C-terminal dimerization motif is required for focal adhesion targeting of Talin1 and the interaction of the Talin1 I/LWEQ module with F-actin. Biochemistry (2007) 1.13
Targeting caspases in cancer therapeutics. Biol Chem (2013) 1.13
A global view of CK2 function and regulation. Mol Cell Biochem (2005) 1.13
Identification of ABR-215050 as lead second generation quinoline-3-carboxamide anti-angiogenic agent for the treatment of prostate cancer. Prostate (2006) 1.13
Expression of myopodin induces suppression of tumor growth and metastasis. Am J Pathol (2004) 1.10
Stromal-epithelial cell interactions and androgen receptor-coregulator recruitment is altered in the tissue microenvironment of prostate cancer. Cancer Res (2007) 1.09
Akt-and CREB-mediated prostate cancer cell proliferation inhibition by Nexrutine, a Phellodendron amurense extract. Neoplasia (2006) 1.09
Gene duplication and functional divergence during evolution of the cytoskeletal linker protein talin. Gene (2005) 1.09
Perlecan, a candidate gene for the CAPB locus, regulates prostate cancer cell growth via the Sonic Hedgehog pathway. Mol Cancer (2006) 1.08
The expression of androgen-responsive genes is up-regulated in the epithelia of benign prostatic hyperplasia. Prostate (2009) 1.08
Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2. J Urol (2003) 1.08
Prostate cancer screening parameters in a high-risk African-Caribbean population. Urology (2004) 1.08
Detection of prostate cancer with a blood-based assay for early prostate cancer antigen. Cancer Res (2005) 1.06
Whole genome SNP arrays as a potential diagnostic tool for the detection of characteristic chromosomal aberrations in renal epithelial tumors. Mod Pathol (2008) 1.05
Significance of talin in cancer progression and metastasis. Int Rev Cell Mol Biol (2011) 1.05
Protein kinase Cdelta signaling downstream of the EGF receptor mediates migration and invasiveness of prostate cancer cells. Biochem Biophys Res Commun (2006) 1.04
Growth factor signalling in prostatic growth: significance in tumour development and therapeutic targeting. Br J Pharmacol (2006) 1.04
Dysfunctional transforming growth factor-beta receptor II accelerates prostate tumorigenesis in the TRAMP mouse model. Cancer Res (2009) 1.04
Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion. Mol Cancer (2012) 1.03
Rho GTPase activity modulates paramyxovirus fusion protein-mediated cell-cell fusion. Virology (2006) 1.02
Doxazosin inhibits human vascular endothelial cell adhesion, migration, and invasion. J Cell Biochem (2005) 1.02
Prohibitin regulates TGF-beta induced apoptosis as a downstream effector of Smad-dependent and -independent signaling. Prostate (2010) 1.01
Pharmacological exploitation of the alpha1-adrenoreceptor antagonist doxazosin to develop a novel class of antitumor agents that block intracellular protein kinase B/Akt activation. J Med Chem (2004) 1.00
Increased cancer cell proliferation in prostate cancer patients with high levels of serum folate. Prostate (2011) 1.00
Utility of a dual immunostain cocktail comprising of p53 and CK20 to aid in the diagnosis of non-neoplastic and neoplastic bladder biopsies. Diagn Pathol (2009) 0.99
Transforming growth factor beta and prostate cancer. Cancer Treat Res (2005) 0.98
Differential proteomic analysis of renal cell carcinoma tissue interstitial fluid. J Proteome Res (2011) 0.98
TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells. Prostate (2008) 0.98
Timing of consent for the research use of surgically removed tissue: is postoperative consenting acceptable? Cancer (2009) 0.97
Novel targeting of apoptosis pathways for prostate cancer therapy. Curr Cancer Drug Targets (2004) 0.94
Biomarkers of phenethyl isothiocyanate-mediated mammary cancer chemoprevention in a clinically relevant mouse model. J Natl Cancer Inst (2012) 0.94
Caspase-dependent apoptosis induction by guggulsterone, a constituent of Ayurvedic medicinal plant Commiphora mukul, in PC-3 human prostate cancer cells is mediated by Bax and Bak. Mol Cancer Ther (2005) 0.93
The conserved C-terminal I/LWEQ module targets Talin1 to focal adhesions. Cell Motil Cytoskeleton (2006) 0.93
Suppressive roles of calreticulin in prostate cancer growth and metastasis. Am J Pathol (2009) 0.93
EMMPRIN regulates cytoskeleton reorganization and cell adhesion in prostate cancer. Prostate (2011) 0.92
Magnetic activated cell sorting allows isolation of spermatogonia from adult primate testes and reveals distinct GFRa1-positive subpopulations in men. J Med Primatol (2009) 0.92
National Mesothelioma Virtual Bank: a standard based biospecimen and clinical data resource to enhance translational research. BMC Cancer (2008) 0.92
Maspin sensitizes prostate cancer cells to doxazosin-induced apoptosis. Oncogene (2005) 0.91
A decade of experience in the development and implementation of tissue banking informatics tools for intra and inter-institutional translational research. J Pathol Inform (2010) 0.91
Cofilin drives cell-invasive and metastatic responses to TGF-β in prostate cancer. Cancer Res (2014) 0.89
Proteasomal regulation of caspase-8 in cancer cell apoptosis. Apoptosis (2013) 0.89